2021
DOI: 10.1177/17151635211035127
|View full text |Cite
|
Sign up to set email alerts
|

The opioid crisis: Naloxone and pharmacists to the rescue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…While I didn’t write an editorial specifically on this until 2021, 49 the need to be proactive is a common theme throughout many of the editorials, for example, the need to be proactive with COVID-19 vaccine hesitancy, 51 prevention of HPV-related cancers 52 and the co-dispensing of naloxone with opioid prescriptions. 53 What’s the use of having a clinical skill that you can’t apply because patients don’t self-identify? You need a plan.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…While I didn’t write an editorial specifically on this until 2021, 49 the need to be proactive is a common theme throughout many of the editorials, for example, the need to be proactive with COVID-19 vaccine hesitancy, 51 prevention of HPV-related cancers 52 and the co-dispensing of naloxone with opioid prescriptions. 53 What’s the use of having a clinical skill that you can’t apply because patients don’t self-identify? You need a plan.…”
mentioning
confidence: 99%
“…38 We also need clearer terminology so that the rest of the health research world can understand us: health services research in pharmacy, rather than pharmacy practice research. 40 • The need to be proactive in our care 49,[51][52][53] : We cannot sit back and expect patients to come to us to ask for health services. While I didn't write an editorial specifically on this until 2021, 49 the need to be proactive is a common theme throughout many of the editorials, for example, the need to be proactive with COVID-19 vaccine hesitancy, 51 prevention of HPV-related cancers 52 and the co-dispensing of naloxone with opioid prescriptions.…”
mentioning
confidence: 99%